AMC6 MED.C.025 Content of aero-medical assessments

• ED Decision 2019/002/R found in: Aircrew (1178/2011) Part-FCL Part-MED Part-CC Part-ARA Part-ORA Part-DTO (Aug 2023)

AMC6 MED.C.025 Content of aero-medical assessments ED Decision 2019/002/R HAEMATOLOGY Cabin crew members with a haematological condition, such as: (a) abnormal haemoglobin including, but not limited to, anaemia, erythrocytosis or haemoglobinopathy; (b) coagulation, haemorrhagic or thrombotic disorder; (c) significant lymphatic enlargement; (d) acute or chronic leukaemia; or (e) splenomegaly may be assessed as fit subject to satisfactory aero-medical evaluation. If anticoagulation is being used as treatment, refer to [AMC2 MED.C.025(c)](#_DxCrossRefBm1199963825). AMC6 MED.C.025 Content of aero-medical assessments ED Decision 2019/002/R HAEMATOLOGY Cabin crew members with a haematological condition, such as: (a)     abnormal haemoglobin including, but not limited to, anaemia, erythrocytosis or haemoglobinopathy; (b)     coagulation, haemorrhagic or thrombotic disorder; (c)      significant lymphatic enlargement; (d)     acute or chronic leukaemia; or (e)     splenomegaly may be assessed as fit subject to satisfactory aero-medical evaluation. If anticoagulation is being used as treatment, refer to [AMC2 MED.C.025(c)](#_DxCrossRefBm894735969). ##### AMC6 MED.C.025 Content of aero-medical assessments *ED Decision 2019/002/R* **HAEMATOLOGY** Cabin crew members with a haematological condition, such as: (a) abnormal haemoglobin including, but not limited to, anaemia, erythrocytosis or haemoglobinopathy; (b) coagulation, haemorrhagic or thrombotic disorder; (c) significant lymphatic enlargement; (d) acute or chronic leukaemia; or (e) splenomegaly may be assessed as fit subject to satisfactory aero-medical evaluation. If anticoagulation is being used as treatment, refer to [AMC2 MED.C.025(c)](#_DxCrossRefBm1743303635).